Company / Capital Returned to Shareholders
Chemed Corp. Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$463.2M
FY2025
5-year range
$91.2M / $598.1M
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#36 of 103
Health Care
What the data says
At $463M, Chemed Corp.'s capital returned to shareholders ranks #36 of 103 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $91M in FY2023 to $598M in FY2021.
Based on SEC 10-K filings.
$463M in FY2025 with a 5-year CAGR of +18.7%.
Improved from $91M to $463M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +50.3%
- 5-Year CAGR
- +18.7%
- 10-Year CAGR
- -
Sector benchmark
-35.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.7%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 19.2% year-over-year.
- Ranks #36 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $463.2M | +19.2% |
| FY2024 | $388.5M | +326.0% |
| FY2023 | $91.2M | -33.2% |
| FY2022 | $136.5M | -77.2% |
| FY2021 | $598.1M | +204.1% |
| FY2020 | $196.7M | +74.9% |
| FY2019 | $112.4M | -36.7% |
| FY2018 | $177.5M | +58.5% |
| FY2017 | $112.0M | -5.7% |
| FY2016 | $118.8M | +58.5% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026